Dawn Timan
Vice President·Norwest
Bio
Professional summary
Dawn Timan is a vice president on Norwest’s Portfolio Success team with more than 20 years of tax experience. She leads tax-related work including domestic and foreign tax planning, income tax filings, submissions and transfer pricing, and also supports regulatory compliance, SOX compliance, internal controls and testing. Before Norwest, she worked in public accounting and with a Fortune 500 company on tax planning and controversy.
Background
Career, education, and skills
Career history
- NorwestVice President2011 – Present
- Public accounting firmSenior Tax Manager
- Fortune 500 companyTax Planning and Controversy
Education
- University of Illinois School of LawJD1991
- Loyola University of ChicagoBBA in Accounting
Other partners at Norwest
12 more profiles
Abishek Balakrishnan
Investor
Norwest
Norwest growth equity investor focused on healthcare services, IT, devices, and digital health.
Aidan Greenstein
Investor
Norwest
Norwest growth equity investor covering technology, business services, media, and consumer.
Amalia Mackenzie
Investor
Norwest
Norwest venture investor focused on consumer and enterprise software.
Amy Brand
Investor
Norwest
Norwest growth equity investor and former Barclays financial sponsors banker.
Andrew Ellis
Investor
Norwest
Norwest growth equity investor focused on software and tech-enabled services.
Angela Johnson
Vice President
Norwest
Norwest growth equity VP focused on technology, business services, media, and consumer.
Anjini K.
Investor
Norwest
Norwest healthtech venture investor with prior Oscar Health and McKinsey experience.
Ankit Prasad
Norwest India
Norwest
Norwest India investor focused on venture and growth equity across Indian companies.
Apurva Oak
Investor
Norwest
Healthcare growth investor focused on software and services at Norwest.
Aria Shah
Investment Professional
Norwest
Growth investment professional with healthcare and venture capital experience.
Assaf Harel
Partner
Norwest
Norwest Partner focused on Israeli-related multi-stage technology investments.
Brian Matesic, MD
Principal
Norwest
Life sciences investor backing early- to mid-stage biotech and medtech companies.